SLC25A32 and neoplasm: Using the GEPIA database to investigate the prognostic significance of SLC25A32 in multiple cancer types, OS and DFS map of SLC25A32 revealed that patients with lower class tumours that highly express SLC25A32 have more adverse OS, including BLCA, BRCA, HNSC, KICH, KIRP, LAML, LUAD, MESO, SARC, and UVM (Figure 5(a)).